Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Development of lentiviral vector respiratory tract dosing methods in anticipation of rodent GLP toxicology assessment

Dettagli Bibliografici
Autori principali:	Sinadinos, A, Sergijenko, A, Meng, C, Gamlin, T, Hyde, S, Gill, DR, Griesenbach, U, Alton, EWFW
Natura:	Conference item
Lingua:	English
Pubblicazione:	Cell Press 2021

Documenti analoghi

Development of protocols for mouse GLP-toxicology studies
di: Sinadinos, A, et al.
Pubblicazione: (2020)

597: Protocol development for mouse toxicology studies using lentiviral gene therapy
di: Sinadinos, A, et al.
Pubblicazione: (2021)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
di: Sergijenko, A, et al.
Pubblicazione: (2021)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
di: Sergijenko, A, et al.
Pubblicazione: (2020)

Gene therapy for respiratory diseases; progress and a changing context
di: Alton, EWFW, et al.
Pubblicazione: (2020)

Low titer lentiviral transgenesis in rodents with simian immundeficiency virus vector
di: Balázs Bender, et al.
Pubblicazione: (2013-09-01)

Lung-targeted lentiviral vector mediates passive immunisation against influenza
di: Tan, T, et al.
Pubblicazione: (2018)

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
di: Helena Lund-Palau, et al.
Pubblicazione: (2022-06-01)

Lung-targeting lentiviral vector for passive immunisation against influenza
di: Tan, TK, et al.
Pubblicazione: (2020)

Cholesterol as an enhancer of lentiviral vector production in serum-free transient transfection
di: Gelinas, J, et al.
Pubblicazione: (2013)

Assessment of selected media supplements to improve F/HN lentiviral vector production yields
di: Gélinas, J, et al.
Pubblicazione: (2017)

Rapid determination of rSIV.F/HN lentiviral vector titre
di: Conway, CC, et al.
Pubblicazione: (2020)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
di: Sinadinos, A, et al.
Pubblicazione: (2020)

Large-scale, high-throughput production of lentiviral vectors for multiple disease applications
di: Ashworth, R, et al.
Pubblicazione: (2018)

Lentiviral Vector Bioprocessing
di: Christopher Perry, et al.
Pubblicazione: (2021-02-01)

Production of lentiviral vectors
di: Otto-Wilhelm Merten, et al.
Pubblicazione: (2016-01-01)

Advances of Lentiviral Vectors
di: Fanrong MENG, et al.
Pubblicazione: (2014-12-01)

A method for assessing the distribution of eGFP expressing cells in the mouse lung following lentiviral vector transduction
di: Munday, R, et al.
Pubblicazione: (2018)

High levels of native eGFP detected following F/HN lentiviral vector transduction of a variety of lung models
di: Munday, R, et al.
Pubblicazione: (2019)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
di: Antepowicz, A, et al.
Pubblicazione: (2021)

The very stable lentiviral vector
di: Gwendolyn K. Binder, et al.
Pubblicazione: (2024-03-01)

Special Issue “Lentiviral Vectors”
di: Yasuhiro Takeuchi
Pubblicazione: (2022-07-01)

The Inside Out of Lentiviral Vectors
di: Stéphanie Durand, et al.
Pubblicazione: (2011-02-01)

Lentiviral and AAV-mediated expression of palivizumab offer protection against Respiratory Syncytial Virus infection
di: Agata Antepowicz, et al.
Pubblicazione: (2021-08-01)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
di: Griesenbach, U, et al.
Pubblicazione: (2011)

Enhanced lentiviral production through rational design of mammalian host cells
di: Hyde, S, et al.
Pubblicazione: (2016)

Lentiviral Vectors for Ocular Gene Therapy
di: Yvan Arsenijevic, et al.
Pubblicazione: (2022-07-01)

Comparison of lentiviral vector titration methods
di: Debyser Zeger, et al.
Pubblicazione: (2006-07-01)

An Improved Protocol for the Production of Lentiviral Vectors
di: Logan Y. Brown, et al.
Pubblicazione: (2020-12-01)

Rev-dependent lentiviral expression vector
di: Beddall Margaret H, et al.
Pubblicazione: (2007-02-01)

Effective gene therapy with nonintegrating lentiviral vectors.
di: Yáñez-Muñoz, R, et al.
Pubblicazione: (2006)

Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance
di: Inès Dufait, et al.
Pubblicazione: (2012-01-01)

Lentiviral Vectors and Cystic Fibrosis Gene Therapy
di: Massimo Conese, et al.
Pubblicazione: (2010-01-01)

Lentiviral Vector Gene Transfer to Porcine Airways
di: Patrick L Sinn, et al.
Pubblicazione: (2012-01-01)

Lentiviral vector pseudotyped with sendai virus F and HN proteins uses sialylated glycan receptors to efficiently target human airway cells
di: Munday, RJ, et al.
Pubblicazione: (2020)

F/HN pseudotyped lentiviral vector uses alpha 2,3 sialylated N-acetyllactosamine to efficiently transduce human airway cells
di: Munday, RJ, et al.
Pubblicazione: (2022)

Moving lentiviral-based gene therapy into a first-in-man CF trial
di: Griesenbach, D, et al.
Pubblicazione: (2015)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
di: Alton, E, et al.
Pubblicazione: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
di: Alton, E, et al.
Pubblicazione: (2014)

Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors
di: Munday, RJ, et al.
Pubblicazione: (2022)